Financial Results( Standalone & Consolidated) for Quarter ended June 30, 2025
MODINATUR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Modi Naturals Ltd submitted its unaudited financial results for the quarter ended June 30, 2025, along with a limited review report from statutory auditors Doogar & Associates, which carried an unmodified (clean) opinion. On a standalone basis, revenue from operations rose to ₹7,565.13 lakhs (from ₹6,989.43 lakhs a year ago, up about 8%), while profit after tax grew to ₹323.97 lakhs (from ₹266.30 lakhs, up about 22%). Standalone EPS stood at ₹2.41 versus ₹2.00. On a consolidated basis, revenue rose to ₹15,602.88 lakhs (from ₹14,765.44 lakhs, up about 5.7%), while profit after tax jumped to ₹1,049.25 lakhs (from ₹745.35 lakhs, up about 41%), giving consolidated EPS of ₹7.87 versus ₹5.61. The subsidiary Modi Biotech Private Limited (100% held) contributed total revenues of ₹7,941.05 lakhs and net profit of ₹725.28 lakhs to consolidated numbers. Separately, the board appointed Mr. Pradeep Kapoor as the new Chief Financial Officer and Key Managerial Personnel effective August 13, 2025.
Consolidated profit after tax grew roughly 41% year-on-year, supported by the subsidiary's contribution and lower finance costs, which is a positive signal for shareholders even though top-line growth was modest. The clean audit opinion and the appointment of an experienced CFO add stability, though retail investors should watch for any continued reliance on GST input credit adjustments at the subsidiary level.